Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: video (4)
heltzen
investor
video
ARCHIVE
ARCHIVE: Go To Market Strategy - part 3 of a fireside chat about Invizyne
January 15, 2025
heltzen
investor
video
ARCHIVE
ARCHIVE: Using AI for Enzyme Engineering - Part 2 of a Fireside Chat About Invizyne
January 7, 2025
heltzen
investor
video
ARCHIVE
ARCHIVE: Looking back at 2024 - part 1 of a fireside chat about Invizyne
December 31, 2024
press release
investor
video
ARCHIVE
ARCHIVE: Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
November 13, 2024
investor
video
ARCHIVE
ARCHIVE: Commercializing Invizyne’s cell-free platform - fireside chat with Zachary Karl, PhD, VP of BizDev - and - Lou Basenese
July 30, 2024
investor
video
ARCHIVE
ARCHIVE: Invizyne IPO: interview with Dr. James J. Lalonde by MDB Capital President and Chief Market Strategist Lou Basenese
July 17, 2024
investor
video
ARCHIVE
ARCHIVE: CEO Michael Heltzen and Co-Founder & VP of Research Dr. Tyler Korman present the Invizyne story and IPO opportunity to investors
June 18, 2024
investor
video
ARCHIVE
ARCHIVE: MDB Capital CEO and Invizyne board member, Chris Marlett, presents the Invizyne story and initial public offering (IPO) opportunity to investors via Zoom on June 11, 2024
June 11, 2024
video
science
ARCHIVE
ARCHIVE: The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth
May 22, 2024
Previous page
Page 4 of 4
Next page